NIVF Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
NewGenIvf Group Ltd (NIVF) is not a good buy for a beginner investor with a long-term focus and $50,000-$100,000 available for investment. The company's financials show significant declines in revenue, net income, EPS, and gross margin. Technical indicators are mixed, with bearish moving averages and no clear upward momentum. Additionally, there are no positive catalysts or trading signals to support a buy decision at this time.
The MACD is positive and expanding, suggesting some momentum, but the RSI is neutral at 55.631, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near its pivot level of 1.95, with resistance at 2.298 and support at 1.602. Overall, the technical outlook is weak.
NULL identified. No recent news or significant insider/hedge fund activity.
The company's financial performance has deteriorated significantly, with revenue down -12.94% YoY, net income down -84822.54% YoY, EPS down -430.88% YoY, and gross margin down -79.11% YoY. Additionally, the stock trend analysis predicts a negative price movement in the short to medium term.
In Q3 2025, the company reported a revenue drop to 1,282,251 (-12.94% YoY), a net income drop to 16,823,355 (-84822.54% YoY), an EPS drop to 97.28 (-430.88% YoY), and a gross margin drop to 9.2 (-79.11% YoY). These metrics indicate severe financial underperformance.
No analyst ratings or price target changes available.
